BCL2 and neoplasm: Downregulation of Mcl-1 but not other antiapoptotic Bcl-2 family proteins potentiated the cell killing efficacy of these specific inhibitors, suggesting that regardless of the tumor lineage, the responsible oncoprotein or the corresponding targeted inhibitors, Mcl-1 was a common resistance factor [59].